Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Depreciation and Depletion (2016 - 2025)

Immucell (ICCC) has disclosed Depreciation and Depletion for 16 consecutive years, with $674314.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation and Depletion rose 0.59% year-over-year to $674314.0, compared with a TTM value of $2.7 million through Sep 2025, changed 0.33%, and an annual FY2024 reading of $2.7 million, down 1.11% over the prior year.
  • Depreciation and Depletion was $674314.0 for Q3 2025 at Immucell, up from $663455.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $695635.0 in Q3 2023 and bottomed at $596424.0 in Q4 2021.
  • Average Depreciation and Depletion over 5 years is $646602.5, with a median of $662477.0 recorded in 2024.
  • The sharpest move saw Depreciation and Depletion grew 11.78% in 2023, then dropped 3.64% in 2024.
  • Year by year, Depreciation and Depletion stood at $596424.0 in 2021, then grew by 0.51% to $599479.0 in 2022, then increased by 11.78% to $670109.0 in 2023, then decreased by 0.15% to $669072.0 in 2024, then rose by 0.78% to $674314.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for ICCC at $674314.0 in Q3 2025, $663455.0 in Q2 2025, and $671191.0 in Q1 2025.